# Prognostic Significance of CMD Assessed by IMR in HCM Patients

> **NCT06190704** · — · COMPLETED · sponsor: **Ya-Wei Xu** · enrollment: 191 (actual)

## Conditions studied

- Coronary Cicrovascular Dysfunction
- Hypertrophic Cardiomyopathy Patients

## Interventions

- **DEVICE:** caIMR

## Key facts

- **NCT ID:** NCT06190704
- **Lead sponsor:** Ya-Wei Xu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-13
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190704, "Prognostic Significance of CMD Assessed by IMR in HCM Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06190704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*